267 related articles for article (PubMed ID: 12560478)
1. Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.
Carbone GM; McGuffie EM; Collier A; Catapano CV
Nucleic Acids Res; 2003 Feb; 31(3):833-43. PubMed ID: 12560478
[TBL] [Abstract][Full Text] [Related]
2. Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.
Carbone GM; Napoli S; Valentini A; Cavalli F; Watson DK; Catapano CV
Nucleic Acids Res; 2004; 32(14):4358-67. PubMed ID: 15314206
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of triplex DNA-mediated inhibition of transcription initiation in cells.
Jain A; Magistri M; Napoli S; Carbone GM; Catapano CV
Biochimie; 2010 Mar; 92(3):317-20. PubMed ID: 20045441
[TBL] [Abstract][Full Text] [Related]
4. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
[TBL] [Abstract][Full Text] [Related]
5. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
6. Sp/Krüppel-like transcription factors are essential for the expression of mitochondrial glycerol phosphate dehydrogenase promoter B.
Hasan NM; MacDonald MJ
Gene; 2002 Aug; 296(1-2):221-34. PubMed ID: 12383520
[TBL] [Abstract][Full Text] [Related]
7. Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma.
Yan S; Berquin IM; Troen BR; Sloane BF
DNA Cell Biol; 2000 Feb; 19(2):79-91. PubMed ID: 10701774
[TBL] [Abstract][Full Text] [Related]
8. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
9. Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.
Bianchi N; Rutigliano C; Passadore M; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):919-27. PubMed ID: 9307046
[TBL] [Abstract][Full Text] [Related]
10. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific transcription of leukotriene C(4) synthase involves a Kruppel-like transcription factor and Sp1.
Zhao JL; Austen KF; Lam BK
J Biol Chem; 2000 Mar; 275(12):8903-10. PubMed ID: 10722737
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
13. Transcription of the human c-Src promoter is dependent on Sp1, a novel pyrimidine binding factor SPy, and can be inhibited by triplex-forming oligonucleotides.
Ritchie S; Boyd FM; Wong J; Bonham K
J Biol Chem; 2000 Jan; 275(2):847-54. PubMed ID: 10625617
[TBL] [Abstract][Full Text] [Related]
14. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
15. Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin.
Rutigliano C; Bianchi N; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Int J Oncol; 1998 Feb; 12(2):337-43. PubMed ID: 9458359
[TBL] [Abstract][Full Text] [Related]
16. Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter.
Mullick J; Anandatheerthavarada HK; Amuthan G; Bhagwat SV; Biswas G; Camasamudram V; Bhat NK; Reddy SE; Rao V; Avadhani NG
J Biol Chem; 2001 May; 276(21):18007-17. PubMed ID: 11279115
[TBL] [Abstract][Full Text] [Related]
17. Competition analysis of the human alpha2(I) collagen promoter using synthetic oligonucleotides.
Ihn H; Tamaki K
J Invest Dermatol; 2000 May; 114(5):1011-6. PubMed ID: 10771485
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
19. Activation of human gamma-globin gene expression via triplex-forming oligonucleotide (TFO)-directed mutations in the gamma-globin gene 5' flanking region.
Xu XS; Glazer PM; Wang G
Gene; 2000 Jan; 242(1-2):219-28. PubMed ID: 10721715
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides.
Marchand P; Resch K; Radeke HH
J Immunol; 2000 Feb; 164(4):2070-6. PubMed ID: 10657660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
